BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 618199)

  • 1. [Study of cardiac excitation and conduction after administration of oxyfedrine. Preliminary observations].
    Franchi F; Padeletti L; Michelucci A; Brat A
    Boll Soc Ital Cardiol; 1977; 22(2):151-7. PubMed ID: 618199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of oxyfedrine on sino-atrial function and on conduction in patients with sinus node and/or atrial dysrhythmias (author's transl)].
    Franchi F; Michelucci A; Padeletti L; Brat A; Fantini F
    G Ital Cardiol; 1977; 7(10):950-9. PubMed ID: 924059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of oxyfedrine on sinus nodal function and AV-conduction (author's transl)].
    Rettig G; Sternitzke N; Sen S; Schmengler K; Schieffer H; Bette L
    Z Kardiol; 1982 Jan; 71(2):119-25. PubMed ID: 7072312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on the A-V conduction of a new antianginal drug: oxyphedryne.
    Zagatti G; Benzoni A; Caturelli G
    Boll Soc Ital Cardiol; 1977; 22(2):189-96. PubMed ID: 618204
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of oxyfedrine on the atrioventricular condutionn system studied using the bundle-of-His electrogram].
    Barbosa J; Lopes AS; Lopes JS; Benchimol CB; Ginefra P; Benchimol AB
    Arq Bras Cardiol; 1976 Aug; 29(4):331-5. PubMed ID: 1008725
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of ildamen on the heart conduction system in ischemic heart disease patients].
    Shilov AM; Borisov VG
    Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 9. [Retardation of the excitation conduction by propaphenone. Duration and dosage effect relation after oral administration (author's transl)].
    Beck OA; Abdulla S; Hochrein H
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1369-72. PubMed ID: 809677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary observations on the use of oxyfedrine in the therapy of angina pectoris].
    Di Lorenzo M; Puddu V
    Minerva Cardioangiol; 1975 Jan; 23(1):3-6. PubMed ID: 806853
    [No Abstract]   [Full Text] [Related]  

  • 11. [Observations on the anti-arrhythmic effects of propafenone].
    Ku FS
    Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):658-61. PubMed ID: 7166067
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M; Noll B; Krappe J
    Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polarizing therapy in intraventricular and atrio-ventricular conduction disorders].
    Loni G; Terreni F
    Cardiol Prat; 1969 Feb; 20(1):65-74. PubMed ID: 4101063
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].
    Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G
    Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac arrhythmias. Types and drug therapy (author's transl)].
    Lehmann HU
    MMW Munch Med Wochenschr; 1981 Apr; 123(17):680-6. PubMed ID: 6164919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diphenylhydantoin and digitalis toxicity].
    Lesbre JP; Cathala B; Salvador M; Florio R; Lescure F; Mériel P
    Arch Mal Coeur Vaiss; 1969 Mar; 62(3):412-37. PubMed ID: 4995353
    [No Abstract]   [Full Text] [Related]  

  • 20. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.